Baxter's Sigma Spectrum Infusion System Awarded "2016 Best in KLAS" Among All Large-Volume Infusion Pumps

Press Release
best in class


Deerfield, Ill - November 10, 2016

Baxter International (NYSE: BAX) today announced the Sigma Spectrum Infusion System was named 2016 Best in KLAS for Smart Pumps – Large Volume Pumps (LVP) in the 2016 Best in KLAS: Medical Equipment report. This is the fifth Best in KLAS award for Sigma Spectrum and is based on feedback from end users as well as opinions of hospital executives and managers who make purchasing decisions.

Receiving the Best in KLAS award signifies Sigma Spectrum outperformed other smart pumps on the market and indicates a high level of customer satisfaction with the platform and its support services. And recently, Sigma Spectrum was recognized in the KLAS “Smart Pumps 2016: The Quest for Patient Safety” report as a leader in drug library compliance and overall ease of use.

The Best in KLAS award reflects Baxter’s commitment to innovative technology for medication delivery designed to enhance patient safety. “Being named Best in KLAS once again is a particular honor because it reflects how Sigma Spectrum pumps are being used to support patient care,” said David Ferguson, Global Head of Baxter’s Fluid Systems Franchise. “Clinicians on the hospital floor need an infusion pump that is easy-to-use, prioritizes patient safety and is backed up by trusted training and support – all areas in which Sigma Spectrum excels.”

KLAS Research specializes in monitoring and reporting the performance of software, services and medical equipment vendors. To inform its latest report, KLAS gathered performance feedback from Sigma Spectrum users, who gave Sigma Spectrum high marks in a number of categories that highlight Sigma Spectrum’s performance and safety at the bedside.

The full “2016 Best in KLAS: Medical Equipment” report is available online at:

About Sigma Spectrum Infusion System

Sigma Spectrum’s hardware works in concert with the pump’s software to encourage use of innovative features that are designed to help enhance patient safety and clinician efficiency. For example, the pumps automatically default to the installed drug library without requiring clinicians to take extra steps to “opt-in,” and drug library updates can be delivered wirelessly to pumps in the facility without interrupting clinical workflow. Sigma Spectrum is the only pump to include a built-in Dose/Rate Change Error Prevention Feature, which helps clinicians protect high-risk infusions during titrations, and allows pharmacists to customize dose change limits for individual drugs. The Sigma Spectrum pump also includes built-in real-time location tracking of equipment within a facility to protect against misplacement, as well as enhanced data analytics and use of standard IV set technology that can yield up to 53 percent cost savings in IV tubing sets and 30 percent reduction in IV tubing use.1

Rx Only. For the safe and proper use of this device, refer to the appropriate operator’s manuals.


About Baxter

Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

Forward-Looking Statements

This release includes forward-looking statements concerning Baxter's Sigma Spectrum Infusion System and related performance data, including anticipated benefits associated with its use. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply issues; patient safety issues; changes in law and regulations; and other risks identified in Baxter's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.


Baxter and Sigma Spectrum are trademarks of Baxter International Inc.